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Abstract The transcription factor c-Fos is a short-lived protein 
and calpains and uhiquitin-dependent systems have been pro- 
posed to be involved in its degradation. In this report, we consider 
a lysosomal degradation pathway for c-Fos. Using a cell-free 
assay, we have found that freshly isolated lysosomes can take up 
and degrade c-Fos with high efficiency, v-Fos, the oncogenic 
counterpart of c-Fos, can also be taken up by lysosomes, yet the 
amount of incorporated protein is much lower, c-Fos uptake is 
independent of its phosphorylation state but it appears to be 
regulated by dimerization with differentially phosphorylated 
forms of c-Jun, while v-Fos escapes this regulation. Moreover, 
we show that c-Fos is immunologically detected in lysosomes 
isolated from the fiver of rats treated with the protease inhibitor 
leupeptin. Altogether, these results suggest that lysosomes can 
also participate in the selective degradation of c-Fos in rat liver. 
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1. Introduction 
A wide variety of extracellular signals which are implicated 
in cellular growth control and differentiation, rapidly and 
transiently induce the transcription of target genes, termed 
early response genes, via changes in the levels of second mes- 
sengers [1]. It has been demonstrated that some of these im- 
mediate early genes belong to the group of so-called proto- 
oncogenes, mutated forms of which are involved in cellular 
transformation [2-5]. The protein products of some of these 
genes are transcription factors which link external stimuli to 
the expression of target late genes [4,6]. Although the number 
of early genes encoding transcription factors identified so far 
is limited, their regulatory effects on gene expression are pleio- 
tropic and vary greatly between cell types and stimuli. Tran- 
scription factors encoded by immediate arly genes have been 
found to share some common features uch as: (1) a rapid 
and often transient induction elicited by physiological or 
pharmacological mitogens [6-8]; (2) short half-lives of mes- 
senger RNAs [9,10]; and (3) short half-lives (20-90 min) of 
their protein products [11,12]. 
Among the early response genes, c-fos and c-jun are mem- 
bers of two families of genes which encode proteins belonging 
to the AP-1 transcription complex. This complex is thought o 
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mediate transcription through TREs (for T PA Responsive 
--Elements) in response to activation of the protein kinase C 
intracellular signal transduction pathway [6,7]. Fos and Jun 
proteins associate to form homo- (Jun-Jun) or heterodimers 
(Jun-Fos) in all conceivable combinations, except Fos homo- 
dimers, which bind to the AP-1 sites of target genes and 
modulate their transcription [6,13,14]. 
The regulation of c-fos gene expression and its product is 
complex and involves transcriptional, post-transcriptional and 
post-translational mechanisms. At the level of transcription, 
both initiation and elongation are regulated by different signal 
transduction pathways, including protein kinases C and A 
routes and rises in intracellular Ca 2÷ concentration [13-17]. 
Post-transcriptional regulation of c-fos occurs via instability 
of the mRNA through the presence of AU-rich destabilizing 
sequences in the 3'-untranslated region [18]. At the post-trans- 
lational level, the activity of the protein is modulated by 
changes in the pattern of phosphorylation, oxidation of spe- 
cific amino acid residues or dimerization with Jun proteins or 
other transcription factors [6,19,20]. 
While the mechanisms regulating ene transcription and 
protein functions have been extensively studied, comparatively 
little is known about the intracellular degradation mechanisms 
of these proteins. These mechanisms may play an important 
role by controlling the intracellular levels of the protein and 
therefore its biological activity, thus representing another level 
of post-translational regulation [21,22]. In this respect, a series 
of previous observations suggest hat at least two proteolytic 
pathways may be involved in c-Fos degradation: calpains [23- 
25] and ubiquitin-dependent systems [26-28]. However, these 
systems were not able to complete the degradation of c-Fos 
monomers, suggesting that additional pathways may also par- 
ticipate in c-Fos degradation. Furthermore, none of the re- 
ported systems was able to degrade v-Fos (the oncogenic 
counterpart of c-Fos). Therefore, we examined in this paper 
if lysosomes, a well-recognized pathway for protein degrada- 
tion, could also participate in these degradative processes. 
2. Materials and methods 
2.1. General 
c-Fos antibodies were obtained from Santa Cruz Biotechnology. 
Western blot analyses were carried out using alkaline phosphatase 
conjugated goat anti-rabbit IgG as secondary antibody. 
The radioactivity associated with the c- and v-Fos proteins in the 
autoradiograms was quantified by phosphorimager analysis using a 
GS-250 Molecular Imager system (Bio-Rad). Statistical analyses were 
carried out with Student's t-test. 
2.2. Fos and Jun proteins 
As a source of c-Fos and v-Fos E300 proteins, a combined in vitro 
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transcription-translation system was used. A plasmid that contained a 
rat cDNA encoding the wild-type c-Fos [29] or pTZE300 encoding v- 
Fos [30] was transcribed (after linearization with HindlII), essentially 
as suggested by the supplier, with either SP6 (c-Fos) or T7 (v-Fos) 
RNA polymerases (Promega). The resulting mRNAs (from 6 gg of 
template DNA) were used in a translation reaction (50 p-l) that con- 
tained nuclease-treated rabbit reticulocyte lysate (40 p.1; Promega) in 
the presence of 6 p-I of L-[35S]methionine (> 1000 Ci/mmol; Amer- 
sham). The in vitro translation reaction was then treated with potato 
acid phosphatase (PAP) for 1 h at 25°C in the presence (mock-treated) 
or absence (PAP-treated) of a mixture of competitive and non-com- 
petitive PAP inhibitors (100 mM NaF, 15 mM Na2MoO4, 20 mM 
(Na2)-p-nitrophenyl phosphate and 10 mM (Na2)-bis-glycerophos- 
phate), as described [31]. Before the cell-free assay, PAP-treated sam- 
ples were quenched with PAP inhibitors. 
cmv-H6cJun protein was purified from untreated or TPA-treated 
transiently transfected HeLa TK- or 293 cells, as described [31]. 
Where indicated, aliquots of mock- or PAP-treated c-Jun (5 gl, 
=25 ng protein) were mixed with [3SS]c-Fos (5 gl that contained 
1 gl of in vitro translated material), mock- or PAP-treated. Reaction 
mixtures were then incubated at 37°C for 30 min to enhance hetero- 
dimerization [31], brought o 30 p-I (final volume) and used in the cell- 
free assay. 
2.3. Preparation of subcellular f actions 
Lysosomes were obtained from rat liver as described [32]. Briefly, a 
mitochondrial-lysosomal fr ction from liver homogenates was pre- 
pared and resuspended in 57% metrizamide (pH 7.0), and 10 ml there- 
of was placed on the bottom of a discontinuous metrizamide gradient. 
The gradient was then centrifuged for 2 h in an SW28 rotor (Beck- 
man) at 141 000×g and five different fractions were obtained. Lyso- 
somes present in the top layer and in the 19.8-24.5 and 24.5~6.3% 
interfaces were collected, pooled together and used in the cell-free 
assay (see below). Mitochondria present in the 26.3-32.8% and 
32.8-57% interfaces were also pooled together and used for Western 
blotting analysis. 
Cytosol [32] and nuclei [33] were obtained from the homogenate as 
described. 
In some experiments, rats were treated with leupeptin (2 mg/100 g 
body weight, intraperitoneally, 1 h before being killed) prior to the 
preparation of the subcellular fractions. 
2.4. Cell-free assay: standard incubation conditions 
Freshly isolated lysosomes were resuspended gently in medium S 
(10 mM Mes.NaOH, pH 7.0, 0.3 M sucrose). Where indicated, lyso- 
somes (~ 5 mg/ml) were incubated for 10 rain at 4°C with 10 mM 
chloroquine (CQ), before adding the substrate proteins. Lysosomes 
(10 p-l, containing ~50 p-g protein) and protein substrates (4 /.tl of 
reticulocyte lysate translation mixture) were incubated, with or with- 
out 10 mM CQ, in medium S (final volume 30 gl), in the presence of 
an ATP regenerating system (1 mM ATP, 8 mM creatine phosphate 
and 40 p-g/ml creatine kinase) for 20 rain at 37°C. Lysosomes were 
pelleted by centrifugation at 10000×g for 5 min at 4°C in a Heraeus 
Biofuge 13, washed once with medium S and analyzed by SDS-PAGE 
and autoradiography. Where indicated, the incubation was followed 
by a treatment with trypsin (100 ng, 10 rain on ice) and then with 
soybean trypsin inhibitor (200 ng, 10 min on ice) prior to the centri- 
fugation steps. 
3. Results 
3.1. c-Fos is taken up in vitro by freshly isolated lysosomes 
We have previously used an in vitro assay to monitor the 
uptake of proteins into rat liver lysosomes [32]. Here, [35S]c- 
Fos was mixed with freshly prepared rat liver lysosomes, in 
medium S, in the absence or presence of chloroquine (CQ) (to 
inhibit intralysosomal proteolysis). After a 20 min incubation 
at 37°C, lysosomes were pelleted by centrifugation, washed 
twice in medium S, and analyzed by SDS-PAGE and auto- 
radiography. 
The amount of c-Fos found in the lysosomal pellets after 
the incubation was higher in the presence of CQ (Fig. 1A, 
compare lanes 2 and 3, 4 and 5), presumably due to the in- 
tralysosomal degradation in the absence of CQ. To analyze 
whether c-Fos was indeed within lysosomes, the incubation 
was followed by a trypsin treatment, to eliminate the protein 
which was simply bound to the external surface of the lyso- 
somal membrane. Under these conditions, proteins which en- 
tered lysosomes are not sensitive to trypsin, since they are 
protected by the lysosomal membrane [32]. After trypsin treat- 
ment, > 50°/'0 of c-Fos remained resistant o the enzyme when 
CQ was present (Fig. 1A, lane 4; see quantification in Table 
1). In the absence of CQ, c-Fos was almost completely de- 
graded (Fig. 1A, lane 5). In the presence of Triton X-100, c- 
Fos was completely degraded by trypsin, whether CQ was 
present or not (not shown). Thus, c-Fos uptake into lyso- 
somes was very efficient, corresponding to ,~ 55% of the pro- 
tein added to the assay. 
c-Fos expressed in a coupled transcription/translation sys- 
tem is phosphorylated [29,30]. Indeed, the inclusion of [7-32P] - 
ATP in the translation mixture yielded labeled protein (data 
not shown). We tested whether the phosphorylation state of c- 
Fos affects its incorporation and degradation by rat liver ly- 
sosomes, c-Fos was treated with PAP to remove all the acces- 
sible phosphate groups. No significant difference was observed 
in its uptake into lysosomes, as compared with c-Fos treated 
with inactivated (mock-treated) PAP (Fig. 1A, compare lanes 
6-9 with lanes 2-5, and see Table 1). This result indicates that 
the phosphorylation state of c-Fos is not important for its 
uptake into lysosomes. 
We then examined whether v-Fos was also taken up by 
lysosomes. As shown in Fig. 1B, v-Fos was incorporated 
into lysosomes, albeit ~3  times less efficiently than c-Fos 
(Table 1). It should be noted that the two bands observed 
for v-Fos are always generated by in vitro transcription/trans- 
lation of the v-Fos encoding construct pTZE300 [30,31], most 
likely the faster migrating species representing leakage in 
either of these processes. 
As is the case for c-Fos, v-Fos synthesized in vitro is also 
phosphorylated, and its uptake into lysosomes was also inde- 
pendent of its phosphorylation state (Table 1). 
3.2. Dimerization with c-Jun prevents c-Fos uptake, unless 
c-Jun is phosphorylated 
c-Fos can heterodimerize with c-Jun through their leucine 
Table 1 
Binding and uptake of c-Fos and v-Fos by freshly isolated lyso- 
somes 
Binding (%) Uptake (%) 
c-Fos 27.2 + 5.4 56.7 + 11.7 
c-Fos-P 26.2 +4.2 54.7 + 8.1 
v-Fos 9.8 + 0.8 25.2 + 1.6 
v-Fos-P 7.4+ 1.4 21.3+ 4.2 
Quantification, using phosphorimager analysis, of the autoradiograms 
from three different experiments a in Fig. 1. The protein adsorbed to 
the external surface of the lysosomes (binding: lanes 3-5 or lanes 7-9) 
and the protein internalized (uptake: lanes 4-5 or lanes 8-9) are 
shown, expressed as a percentage of the total protein added to the 
assay (4 times the radioactivity present in lane 1, see legend to Fig. 1) 
[32,34]. For the quantification of v-Fos, the two observed bands (see 
Section 3) were taken into account [30,31]. The protein that was 
associated with lysosomes in the presence of chloroquine (lanes 2 
and 6) roughly corresponds to the sum of the surface-bound and 
internalized proteins (data not shown, and [32,34]). 
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zippers to form the AP-1 transcription factor. The transcrip- 
tional activity and DNA binding properties of the heterodi- 
mer are regulated by signal-dependent phosphorylation and 
dephosphorylation events [19]. We therefore tested the influ- 
ence of dimerization with c-Jun and phosphorylation i  the 
uptake and degradation of c-Fos by freshly isolated rat liver 
lysosomes. 
When c-Fos was dimerized with cmv-H6cJun (an artificial 
derivative of c-Jun containing an hexahistidine s quence at its 
amino terminus to allow rapid purification from transfected 
cells while preserving its phosphorylation state [31]), no sig- 
nificant effect was seen on c-Fos lysosomal uptake (Fig. 2A, 
compare lanes 1-2 and 5-6; see quantification i  Fig. 2B). 
However, when c-Fos was dimerized with cmv-H6cJun treated 
with PAP to remove all accessible phosphate groups, uptake 
was significantly decreased (Fig. 2A, compare lanes 1-2 and 
3-4). This suggests that the phosphorylation state of c-Jun 
may play a role in c-Fos uptake and degradation by liver 
lysosomes. 
Moreover, c-Fos was dimerized with hypophosphorylated 
cmv-H6cJun protein (purified from TPA-treated cells). Then, 
the uptake of c-Fos into lysosomes was significantly decreased 
(Fig. 2A, compare lanes 1-2 and 7-8). Altogether, these re- 
sults imply that the phosphorylation state of c-Jun partially 
controls the incorporation and subsequent degradation of c- 
Fos by intact lysosomes. 
3.3. Dimerization with c-Jun does not affect v-Fos uptake 
We also investigated whether v-Fos uptake was modified 
upon dimerization with c-Jun, as was the case for c-Fos. As 
shown in Fig. 3, v-Fos uptake was not affected upon dimer- 
ization with cmv-H6cJun, regardless of the phosphorylation 
state of the latter (see Fig. 3A and quantification in Fig. 
3B). Therefore, v-Fos seems to escape the regulation mechan- 
ism observed for c-Fos. 
3.4. Immunological detection of  c-Fos in liver lysosomes 
To test whether lysosomes could be involved in the degra- 
dation of c-Fos in vivo, we investigated if c-Fos was present in 
freshly isolated rat liver lysosomes. Rat liver fractions [32] 
were analyzed by SDS-PAGE followed by Western blotting 
with a c-Fos antibody (Fig. 4). c-Fos (62 kDa, lane 6) was 
detected in whole homogenates (Fig. 4, lane 1) and mainly 
distributed in the nuclei (Fig. 4, lane 2), where the protein 
exerts its function, and in the cytosol (Fig. 4, lane 3), where 
the protein is synthesized to be subsequently incorporated into 
the nucleus, c-Fos was not detected in mitochondria (Fig. 4, 
lane 4), as expected, but it was present in lysosomes of rats 
treated with leupeptin prior to being killed (Fig. 4A, lane 5). 
Under these conditions, lysosomal proteases are inhibited, 
providing a means to detect proteins within lysosomes which 
otherwise would be rapidly degraded [32,35]. No detectable 
signal was seen in lysosomes isolated from control rats, i.e. 
when the lysosomal proteases were not inhibited by leupeptin 
injection (Fig. 4B, lane 5), whereas other subcellular fractions 
contained similar amounts of c-Fos (i.e. nuclei or cytosol, 
compare lanes 2 and 3 in Fig. 4A,B). Furthermore, the 
amounts of c-Fos associated with lysosomal fractions were, 
at least partially, resistant o trypsin treatment. Addition of 
Triton X-100 to solubilize lysosomal membranes completely 
abolished this resistance, indicating that c-Fos was located 
inside the lysosomes (Fig. 4C). This suggests that in rat liver 
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Fig. 1. c-Fos and v-Fos are taken up in vitro by freshly isolated ly- 
sosomes. A: A synthetic RNA encoding rat c-Fos protein was 
translated in a rabbit reticulocyte lysate in the presence of 
[35S]methionine. The in vitro translation reaction was then treated 
with PAP in the presence (mock-treated) or in the absence (PAP- 
treated) of a cocktail of PAP inhibitors. Lysosomes, prepared as de- 
scribed in Section 2, were resuspended in freshly prepared medium 
S and incubated with (+) or without ( -)  10 mM chloroquine (CQ) 
for 10 min on ice. Lysosomes (50 gg) were then incubated with c- 
Fos (4 gl of the reticulocyte lysate translation mixture), PAP-treated 
(c-Fos, lanes 6-9) or mock-treated (c-Fos-P, lanes ~5), under the 
standard incubation conditions, in the presence (lanes 2, 4, 6 and 8) 
or absence (lanes 3, 5, 7 and 9) of CQ. Where indicated (lanes 4, 5, 
8 and 9), the samples were treated with trypsin as described in Sec- 
tion 2. Finally, lysosomes were pelleted by centrifugation, washed in 
medium S, and analyzed by SDS-PAGE and autoradiography. B: 
The experiment was as in A, but using v-Fos (4 gl of reticulocyte 
lysate translation mixture), PAP-treated (v-Fos, lanes 6-9) or mock- 
treated (v-Fos-P, lanes ~5), instead of c-Fos. Lane 1 contains 1 gl 
of the reticulocyte lysate translation mixture, containing c-Fos (A) 
or v-Fos (B). 
c-Fos may be degraded, at least in part, by a lysosomal mech- 
anism. 
4. Discussion 
At least two different proteolytic pathways have been pro- 
posed to be involved in c-Fos degradation: ubiquitin/protea- 
somes [26-28] and calpains [23-25]. These studies have been 
focused on non-lysosomal pathways, because they have been 
mostly implicated in the degradation of short-lived proteins 
[36]. However, since it is possible that more than one pathway 
may be necessary to complete c-Fos degradation [24] and 
lysosomes are also a major site of intracellular protein degra- 
dation [37-39], we investigated if these organelles could also 
play a role in the degradation of c-Fos. 
Indeed, uptake of c-Fos by freshly isolated lysosomes in a 
cell-free assay was very efficient (55% of the synthesized pro- 
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tein) and thus compatible with the short half-life exhibited by 
the protein [11,12]. Also, the detection of  c-Fos in liver lyso- 
somes isolated from leupeptin-treated rats is consistent with a 
lysosomal mechanism being involved in the degradation of  c- 
Fos in rat liver. 
We have studied if dimerization of  c-Fos with c-Jun can 
affect the degradation of  the protein in the lysosomal cell- 
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Fig. 2. Dimerization with c-Jun prevents c-Fos uptake by freshly 
isolated lysosomes, unless c-Jun is phosphorylated. A: The cmv- 
HrcJun protein (lanes 3-6, ~ 50 ng) purified from transiently trans- 
fected HeLa TK- cells, PAP-treated (c-Jun, lanes 34)  or mock- 
treated (c-Jun-P, lanes 5-6), or the cmv-HrcJun protein purified 
from TPA-stimulated transiently transfected 293 cells [c-Jun (TPA), 
lanes 7-8] were mixed with [s~S]c-Fos (mock-treated, c-Fos-P). In 
lanes 1-2, c-Fos was not mixed with any Jun protein. Reaction mix- 
tures were then incubated at 37°C for 30 min to enhance heterodi- 
merization and then incubated with freshly prepared lysosomes, in 
the absence (lanes 2, 4, 6 and 8) or presence (lanes 1, 3, 5 and 7) of 
10 mM CQ, as in Fig. 1. After the incubation, the samples were 
treated with trypsin, as described in Section 2. Finally, lysosomes 
were pelleted by centrifugation, washed in medium S and analyzed 
by SDS-PAGE and autoradiography. The figure depicts a typical 
gel. B: Quantification, using phosphorimager analysis, of the auto- 
radiograms from three different experiments as in A. Each bar is 
the result of subtracting the radioactivity of the bands in the pres- 
ence and absence of CQ; i.e. c-Fos-P, lanes 1 and 2, c-Fos-P/c-Jun, 
lanes 3 and 4, c-Fos-P/c-Jun-P, lanes 5 and 6, and c-Fos-P/c-Jun 
(TPA), lanes 7 and 8. Results are means + S.D. Statistical signifi- 
cance with respect to c-Fos-P values: *P < 0.025 and **P < 0.0025. 
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Fig. 3. Dimerization with c-Jun does not affect v-Fos uptake by 
freshly isolated lysosomes. The experiment was performed exactly as 
in Fig. 2, except that v-Fos protein was used instead of c-Fos. A: 
Typical gel from such an experiment. B: Quantification of the auto- 
radiograms from three different experiments as in A. 
free system. Our results clearly show that the lysosomal up- 
take of  c-Fos for degradation depends on the c-Jun phosphor- 
ylation state: non-phosphorylated forms (PAP-treated) of  c- 
Jun partially impair c-Fos degradation. This conclusion is 
further supported by the intermediate effect on c-Fos degra- 
dation of dimerization with hypophosphorylated forms (pur- 
ified from TPA-treated cells) of  c-Jun. In contrast, dimeriza- 
tion with phosphorylated or non-(hypo-)phosphorylated c-Jun 
did not change the rate of  v-Fos lysosomal uptake. 
Similar effects were observed for the degradation of  c-Fos 
in a reticulocyte lysate [31] and the proteolytic pathway in- 
volved was recently identified as that comprising ubiquitin/ 
proteasomes [27,28]. This system, which in contrast to lyso- 
somes cannot degrade c-Fos monomers to any significant ex- 
tent, can degrade c-Fos dimerized with phosphorylated c-Jun 
[27,28,31]. Whether dimerization also affects degradation of  c- 
Fos by calpains remains to be investigated. However, calpains 
are unable to complete c-Fos degradation (i.e. degradation 
intermediates accumulate) and, as discussed by the authors 
[24], the calcium levels used to degrade c-Fos by calpains 
are high above the normal calcium levels found within cells 
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Fig. 4. Immunolocalization f c-Fos in rat liver fractions. Rats were 
treated (A) or not (B) with leupeptin (2 mg/100 g weight, intraperi- 
toneally, 1 h before being killed) and liver fractions were prepared 
as described in Section 2. Proteins (15 ktg) from the various frac- 
tions were separated by SDS-PAGE and immunoblotted with a 
polyclonal antibody against c-Fos and alkaline phosphatase-conju- 
gated goat anti-rabbit IgG as secondary antibody. Lane 1, homoge- 
nate; lane 2, nuclei; lane 3, cytosol; lane 4, mitochondria; lane 5, 
lysosomes; lane 6, 1 pJ of the reticulocyte lysate translation mixture 
containing in vitro synthesized c-Fos. C: Lysosomes (30 ktg of pro- 
tein) prepared as described in Section 2, from rats treated with leu- 
peptin (as in A), were incubated with trypsin (0.5 txg), in the ab- 
sence (lane 2) or presence (lane 3) of 1% Triton X-100 before SDS- 
PAGE and immunoblotting with the c-Fos antibody. 
[40]. At any rate, it appears that the mechanism for destabi- 
lization of c-Fos is similarly recognized by both non-lysoso- 
mal (ubiquitin/proteasomes) [27,28,31] and lysosomal (this pa- 
per) degradative pathways. This probably increases the 
effÉciency for selectively removing short-lived proteins and 
provides another example of the universality of signals for 
protein degradation, already exemplified by the ubiquitin tar- 
geting of proteins to non-lysosomal [41,42] and lysosomal 
degradative pathways [43,44]. 
In contrast o non-lysosomat pathways, lysosomes can also 
degrade v-Fos, albeit with lower efficiency than c-Fos (Table 
1). This difference, together with the resistance of v-Fos to 
degradation by non-lysosomal proteolytic pathways [27,31], 
is likely to contribute to v-Fos oncogenicity. In this respect, 
the major change when comparing c-Fos to v-Fos sequences i
the lack of 48 amino acid residues in the v-Fos C-terminus. 
Interestingly, the lysosomal efficiency in incorporating v-Fos 
is quite similar to that obtained when c-Fos heterodimerizes 
with non-phosphorylated forms (PAP-treated) of c-Jun. This 
suggests that two different lysosomal uptake mechanisms co- 
exist in the cell-free assay of lysosomal degradation: non-se- 
lective (most probably, non-specific microautophagy [22]) and 
selective (either direct protein transfer across the lysosomal 
membrane [45] or specific microautophagy). The first mecha- 
nism would contribute to a basal degradation of all proteins, 
including v-Fos and the active form of AP-1, whereas the 
second mechanism would selectively recognize some still un- 
identified specific signals in the transcriptionally inactive c-Fos 
monomers and Fos-Jun heterodimers and degrade them. It 
should be noted that heterodimers of c-Fos and phosphory- 
lated c-Jun are unable to bind TRE motifs, contrary to het- 
erodimers formed between c-Fos and c-Jun isolated from 
TPA-treated cells (A.G. Papavassiliou, unpublished ata). 
The signals which modulate c-Fos degradation, such as het- 
erodimerization with different phosphorylated forms of c-Jun, 
the exact sequence(s) in the C-terminal region missing in v- 
Fos, or others need to be characterized more precisely. 
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